Fabrizio Bortolotti
- Molecular Biology
- Pharmaceutical Science top 0.5%
- Organic Chemistry top 10%
- Biomaterials top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- Enea MenegattiPaolo AscenziAlessandro DalpiazRita CortesiGaia ColomboGheorghe FundueanuMarieta ConstantinAngelo Scatturin
- Topics
- Advanced Drug Delivery Systems (11 papers)HIV/AIDS drug development and treatment (10 papers)Click Chemistry and Applications (7 papers)
- Journals
- BiomaterialsBiochemistryFEBS Letters
- Partner nations
- ItalyUnited StatesGreece
In The Last Decade
Fabrizio Bortolotti
56 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 121
- Molecular Biology 504
- Pharmaceutical Science 431
- Organic Chemistry 165
- Biomaterials 164
- Pulmonary and Respiratory Medicine 144
Countries citing papers authored by Fabrizio Bortolotti
This map shows the geographic impact of Fabrizio Bortolotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrizio Bortolotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrizio Bortolotti more than expected).
Fields of papers citing papers by Fabrizio Bortolotti
This network shows the impact of papers produced by Fabrizio Bortolotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrizio Bortolotti. The network helps show where Fabrizio Bortolotti may publish in the future.
Co-authorship network of co-authors of Fabrizio Bortolotti
This figure shows the co-authorship network connecting the top 25 collaborators of Fabrizio Bortolotti. A scholar is included among the top collaborators of Fabrizio Bortolotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabrizio Bortolotti. Fabrizio Bortolotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 105 | |
| 2 | 27 | |
| 3 | 43 | |
| 4 | 3 | |
| 5 | 18 | |
| 6 | 64 | |
| 7 | 22 | |
| 8 | 7 | |
| 9 | 33 | |
| 10 | 20 | |
| 11 | 55 | |
| 12 | 30 | |
| 13 | 16 | |
| 14 | 45 | |
| 15 | 56 | |
| 16 | 5 | |
| 17 | Structure-activity relationships of HIV-1 protease inhibitors containing gem-diaminoserine core unit. | 3 |
| 18 | 1 | |
| 19 | 7 | |
| 20 | 29 |
About Fabrizio Bortolotti
Fabrizio Bortolotti is a scholar working on Pharmaceutical Science, Physiology and Virology, having authored 57 papers that have together received 1.4k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (11 papers), HIV/AIDS drug development and treatment (10 papers) and Click Chemistry and Applications (7 papers). The work is most often cited by research in Pharmaceutical Science (431 citations), Molecular Medicine (143 citations) and Physiology (70 citations). Fabrizio Bortolotti has collaborated with scholars based in Italy, United States and Greece. Frequent co-authors include Enea Menegatti, Paolo Ascenzi, Alessandro Dalpiaz, Rita Cortesi, Gaia Colombo, Gheorghe Fundueanu, Marieta Constantin, Angelo Scatturin, Paola Russo and Fabio Sonvico. Their work appears in journals such as Biomaterials, Biochemistry and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.